Biography
Shoshana Shendelman is a scientist and entrepreneur, founder of several biotech companies, and a pioneer in developing drugs for rare and underserved diseases. She currently holds leadership roles in several private biotech companies and serves as CEO of Cyana Therapeutics, an oncology company developing drugs to treat solid tumors.
Previously, Shoshana founded and led a pharmaceutical company through IPO and advanced drugs through phase 3 development for rare disease indications and heart failure.
Shoshana completed a BA in biochemistry at Brandeis University and received a PhD from Columbia University Vagelos College of Physicians and Surgeons Integrated Program in Cellular, Molecular and Biophysical Studies.